202 related articles for article (PubMed ID: 29054416)
1. Targeting the Selenoprotein Thioredoxin Reductase 1 for Anticancer Therapy.
Arnér ESJ
Adv Cancer Res; 2017; 136():139-151. PubMed ID: 29054416
[TBL] [Abstract][Full Text] [Related]
2. Pyrroloquinoline quinone modulates the kinetic parameters of the mammalian selenoprotein thioredoxin reductase 1 and is an inhibitor of glutathione reductase.
Xu J; Arnér ES
Biochem Pharmacol; 2012 Mar; 83(6):815-20. PubMed ID: 22226931
[TBL] [Abstract][Full Text] [Related]
3. Thioredoxin Reductase Inhibition for Cancer Therapy.
Gencheva R; Arnér ESJ
Annu Rev Pharmacol Toxicol; 2022 Jan; 62():177-196. PubMed ID: 34449246
[TBL] [Abstract][Full Text] [Related]
4. DIAPH3 promotes pancreatic cancer progression by activating selenoprotein TrxR1-mediated antioxidant effects.
Rong Y; Gao J; Kuang T; Chen J; Li JA; Huang Y; Xin H; Fang Y; Han X; Sun LQ; Deng YZ; Li Z; Lou W
J Cell Mol Med; 2021 Feb; 25(4):2163-2175. PubMed ID: 33345387
[TBL] [Abstract][Full Text] [Related]
5. The conserved Trp114 residue of thioredoxin reductase 1 has a redox sensor-like function triggering oligomerization and crosslinking upon oxidative stress related to cell death.
Xu J; Eriksson SE; Cebula M; Sandalova T; Hedström E; Pader I; Cheng Q; Myers CR; Antholine WE; Nagy P; Hellman U; Selivanova G; Lindqvist Y; Arnér ES
Cell Death Dis; 2015 Jan; 6(1):e1616. PubMed ID: 25611390
[TBL] [Abstract][Full Text] [Related]
6. Ethaselen: a potent mammalian thioredoxin reductase 1 inhibitor and novel organoselenium anticancer agent.
Wang L; Yang Z; Fu J; Yin H; Xiong K; Tan Q; Jin H; Li J; Wang T; Tang W; Yin J; Cai G; Liu M; Kehr S; Becker K; Zeng H
Free Radic Biol Med; 2012 Mar; 52(5):898-908. PubMed ID: 22210352
[TBL] [Abstract][Full Text] [Related]
7. Oxidation of structural cysteine residues in thioredoxin 1 by aromatic arsenicals enhances cancer cell cytotoxicity caused by the inhibition of thioredoxin reductase 1.
Zhang X; Lu J; Ren X; Du Y; Zheng Y; Ioannou PV; Holmgren A
Free Radic Biol Med; 2015 Dec; 89():192-200. PubMed ID: 26169724
[TBL] [Abstract][Full Text] [Related]
8. A diterpenoid derivate compound targets selenocysteine of thioredoxin reductases and induces Bax/Bak-independent apoptosis.
Liu J; Mu C; Yue W; Li J; Ma B; Zhao L; Liu L; Chen Q; Yan C; Liu H; Hao X; Zhu Y
Free Radic Biol Med; 2013 Oct; 63():485-94. PubMed ID: 23732520
[TBL] [Abstract][Full Text] [Related]
9. Regulation of the mammalian selenoprotein thioredoxin reductase 1 in relation to cellular phenotype, growth, and signaling events.
Rundlöf AK; Arnér ES
Antioxid Redox Signal; 2004 Feb; 6(1):41-52. PubMed ID: 14980055
[TBL] [Abstract][Full Text] [Related]
10. TrxR1 as a potent regulator of the Nrf2-Keap1 response system.
Cebula M; Schmidt EE; Arnér ES
Antioxid Redox Signal; 2015 Oct; 23(10):823-53. PubMed ID: 26058897
[TBL] [Abstract][Full Text] [Related]
11. Selenoproteins in Tumorigenesis and Cancer Progression.
Short SP; Williams CS
Adv Cancer Res; 2017; 136():49-83. PubMed ID: 29054422
[TBL] [Abstract][Full Text] [Related]
12. TrxR1, Gsr, and oxidative stress determine hepatocellular carcinoma malignancy.
McLoughlin MR; Orlicky DJ; Prigge JR; Krishna P; Talago EA; Cavigli IR; Eriksson S; Miller CG; Kundert JA; Sayin VI; Sabol RA; Heinemann J; Brandenberger LO; Iverson SV; Bothner B; Papagiannakopoulos T; Shearn CT; Arnér ESJ; Schmidt EE
Proc Natl Acad Sci U S A; 2019 Jun; 116(23):11408-11417. PubMed ID: 31097586
[TBL] [Abstract][Full Text] [Related]
13. Interplay between cytosolic disulfide reductase systems and the Nrf2/Keap1 pathway.
Schmidt EE
Biochem Soc Trans; 2015 Aug; 43(4):632-8. PubMed ID: 26551704
[TBL] [Abstract][Full Text] [Related]
14. Substrate and inhibitor specificities differ between human cytosolic and mitochondrial thioredoxin reductases: Implications for development of specific inhibitors.
Rackham O; Shearwood AM; Thyer R; McNamara E; Davies SM; Callus BA; Miranda-Vizuete A; Berners-Price SJ; Cheng Q; Arnér ES; Filipovska A
Free Radic Biol Med; 2011 Mar; 50(6):689-99. PubMed ID: 21172426
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory nitrosylation of mammalian thioredoxin reductase 1: Molecular characterization and evidence for its functional role in cellular nitroso-redox imbalance.
Engelman R; Ziv T; Arnér ESJ; Benhar M
Free Radic Biol Med; 2016 Aug; 97():375-385. PubMed ID: 27377780
[TBL] [Abstract][Full Text] [Related]
16. Menadione inhibits thioredoxin reductase 1 via arylation at the Sec
Sun S; Xu W; Zhang Y; Yang Y; Ma Q; Xu J
Free Radic Biol Med; 2021 Aug; 172():482-489. PubMed ID: 34186208
[TBL] [Abstract][Full Text] [Related]
17. Focus on mammalian thioredoxin reductases--important selenoproteins with versatile functions.
Arnér ES
Biochim Biophys Acta; 2009 Jun; 1790(6):495-526. PubMed ID: 19364476
[TBL] [Abstract][Full Text] [Related]
18. [Selenoprotein thioredoxin reductase mediated menadione reduction: catalytic properties & inhibition effects].
Zhang N; Sun S; Zhang Y; Yang Y; Zhang Y; Chen J; Xu W; Ma Q; Xu J
Sheng Wu Gong Cheng Xue Bao; 2020 Oct; 36(10):2139-2150. PubMed ID: 33169578
[TBL] [Abstract][Full Text] [Related]
19. Irreversible inhibition of cytosolic thioredoxin reductase 1 as a mechanistic basis for anticancer therapy.
Stafford WC; Peng X; Olofsson MH; Zhang X; Luci DK; Lu L; Cheng Q; Trésaugues L; Dexheimer TS; Coussens NP; Augsten M; Ahlzén HM; Orwar O; Östman A; Stone-Elander S; Maloney DJ; Jadhav A; Simeonov A; Linder S; Arnér ESJ
Sci Transl Med; 2018 Feb; 10(428):. PubMed ID: 29444979
[TBL] [Abstract][Full Text] [Related]
20. The expression and activity of thioredoxin reductase 1 splice variants v1 and v2 regulate the expression of genes associated with differentiation and adhesion.
Nalvarte I; Damdimopoulos AE; Rüegg J; Spyrou G
Biosci Rep; 2015 Oct; 35(6):. PubMed ID: 26464515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
